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ABSTRACT 
The dose-related inhibition  by colchicine of both lysosomal enzyme release and 
microtubule  assembly  was  studied  in  human  polymorphonuclear  leukocytes 
(PMN) exposed to the nonphagocytic stimulus,  zymosan-treated  serum  (ZTS). 
Cells were pretreated with colchicine (60 min, 37~  with or without cytochalasin 
B (5/.~g/ml,  10 min) and then stimulated with ZTS (10%). Microtubule numbers 
in both cytochalasin B-treated and untreated PMN were increased by stimulation 
and  depressed  below  resting  levels  in  a  dose-response  fashion  by  colchicine 
concentrations above 10  -7 M. These concentrations also inhibited enzyme release 
in a  dose-response fashion although the inhibition  of microtubule assembly was 
proportionately greater than  the inhibition  of enzyme release.  Other aspects of 
PMN morphology were affected by colchicine. Cytochalasin B-treated PMN were 
rounded, and in thin sections the retracted plasma membrane appeared as invagi- 
nations  oriented  toward  centrally  located  centrioles.  Membrane  invaginations 
were restricted to the cell periphery in cells treated with inhibitory concentrations 
of colchicine, and the centrioles and  Golgi apparatus were displaced from their 
usual  position.  After  stimulation  and  subsequent  degranulation,  the  size  and 
number of membrane invaginations greatly increased. They remained peripheral 
in cells pretreated with >  10  -7 M colchicine but were numerous in the pericentrio- 
lar region in cells treated  with  <  10  -r M.  Similarly, untreated  PMN that  were 
permitted to phagocytose immune precipitates had many phagosomes adjacent to 
the centriole. After colchicine treatment, phagosomes were distributed randomly, 
without any preferential association with the centrioles. These data suggest that 
microtubules are involved in maintaining the internal organization of cells and the 
topologic relationships between organelles and the plasma membrane. 
Secretion  of  previously  "packaged"  molecules 
from a variety of cell types appears to be depend- 
ent upon the normal function of cytoplasmic mi- 
crotubules since the process is inhibitable by col- 
chicine and other microtubule-active agents (3, 4, 
12, 21, 24, 35, 36). The precise role of microtu- 
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difficult to  elucidate,  since  morphologic studies 
have demonstrated relatively few microtubules in 
secretory cells, and  those  microtubules that  are 
seen do not appear to be oriented with respect to 
the organelles whose mobility they putatively con- 
trol. Recent evidence (1) indicates that only 35- 
40% of the tubulin pool in secretory cells is in the 
assembled form. The remainder probably assem- 
bles into  functional microtubules in response  to 
secretory stimuli.  Thus,  most  of those  microtu- 
bules seen in secretory cells under resting condi- 
tions may not represent the population involved in 
secretory events. 
Colchicine,  the  drug  used  in  most  studies  of 
microtubule function, binds to depolymerized tu- 
bulin and prevents its subsequent polymerization 
into functional microtubules (34). Only a fraction 
of the  theoretical  number  of tubulin  molecules 
need be complexed with colchicine to prevent po- 
lymerization (17).  Although  colchicine binds  to 
membrane proteins (1, 26,  27),  the high affinity 
binding sites appear to  be  membrane-associated 
tubulin (1, 27). However, in order to ascribe the 
effects of colchicine on cell function to its effect on 
microtubule  polymerization,  it  is  necessary  to 
combine biochemical studies of cell function with 
ultrastructural studies of microtubule assembly. 
Secretion of lysosomal enzymes by human poly- 
morphonuclear  leukocytes  (PMN) ~ is  similar to 
secretion of stored proteins by other cell types (6, 
8,  9,  31,  32,  38).  Enzyme  secretion  occurs  in 
response to a number of phagocytic and nonphag- 
ocytic stimuli and is associated with enhanced mi- 
crotuhule assembly (6,  11, 33). Secretion can be 
partially inhibited by colchicine (13,  18, 39) and 
by agents which increase cellular levels of cyclic 
3',5'-adenosine monophosphate (41,42), and can 
be enhanced by agents which increase cyclic 3' ,5'- 
guanosine monophosphate (41,42). We have pre- 
viously  reported  positive  correlations  between 
pharmacological modulation  of in  vivo microtu- 
hule assembly and enzyme release (33) and conse- 
quently have designed the experiments described 
below  to  test  whether  colchicine concentrations 
that  inhibited  biochemically  measured  enzyme 
release from stimulated PMN also inhibited micro- 
tubule assembly. 
i Abbreviations used in this paper: PMN, polymorpho- 
nuclear  leukocyte(s);  ZTS,  zymosan-treated  serum; 
LDH, lactate dehydrogenase. 
In these experiments microtubule assembly was 
stimulated in both cytochalasin B-treated and un- 
treated PMN by serum in which complement was 
activated via the alternate pathway by zymosan- 
treated serum (ZTS). Such a fluid phase stimulus 
provides  a  population  of  uniformly  stimulated 
cells which are amenable to electron microscope 
morphometry  of  microtubule  assembly in  vivo. 
Furthermore, cytochalasin B-treated PMN release 
lysosomal  enzymes  to  the  extracellular  milieu 
upon  stimulation  by  ZTS.  Thus,  microtubule 
assembly and  lysosomal enzyme  release  can  be 
studied in  the  same  system.  The  data  reported 
here provide morphologic confirmation that col- 
chicine concentrations that inhibit enzyme release 
from PMN also inhibit microtubule assembly in a 
dose-related fashion.  They  also suggest that  the 
process  affected  by  the  absence  of  functional 
microtubules is the  ability to translocate phago- 
cytic  vacuoles  from  the  cell  periphery  to  the 
granule-rich, pericentriolar cytoplasm. 
MATERIALS  AND  METHODS 
Preparation  of PMN 
Venous blood (32 ml) was drawn from healthy adult 
volunteers and mixed with 8 ml of acid citrate dextrose 
(ACD)  anticoagulant  (National  Institutes  of  Health 
formula A) plus 20 ml of 6% dextran in normal saline. 
The erythrocytes were allowed to sediment 30-45 min- 
utes.  Portions  (15 ml) of the leukocyte-rich supemates 
were then mixed with 35 ml of 0.87% ammonium chlo- 
ride and centrifuged for 10 min at 160g. The cell pellets 
were resuspended  in normal saline, combined in a vol- 
ume  of 50  ml,  and centrifuged  at  160 g  for  10  min. 
The resulting pellet was suspended  in buffer (138  mM 
NaC1,  2.7  mM  KCI,  8.1  mM  Na~HPO4,  1.5  mM 
KI-I~PO4, 0.6 mM CaCi~, and 1.0 mM MgCI2, pH 7.4). 
Aliquots containing  2  x  106 PMN  were  preincubated 
with varying concentrations of colchicine (Sigma Chemi- 
cal Co., St. Louis, Mo.) at 37~  for 1 h. Cytochalasin B 
(5  /~g/ml) (ICI Research  Laboratories, Alderly Park, 
Cheshire, Eng.) in 0.1% dimethyl sulfoxide (Matheson, 
Coleman and Bell, East Rutherford, N. J.) was added 
for the last 10 min before addition of ZTS. This concen- 
tration  of  dimethyl  sulfoxide  did  not  influence  cell 
morphology, enzyme release or enzyme assays. 
Activation of Complement 
Complement was activated in fresh autologous serum 
containing  250  mM  epsilon-aminocaproic  acid (Sigma 
Chemical Co.) by adding zymosan (1.0 mg/ml). After 15 
min of incubation at 37~  the serum was rendered free 
of  particles  by  centrifugation  (3,000  g).  Zymosan- 
treated  serum  containing  epsilon-aminocaproic  acid 
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concentration of 10% (vol/vol), and enzyme release was 
measured after 5 rain, by which time maximal enzyme 
release has been achieved in this system. The bulk of 
evidence regarding the identity of the lysosomal enzyme- 
releasing activity obtained by  these  methods indicates 
that it is a  low  molecular  weight (-  17,000  daltons) 
product of C5, probably C5a (6). Chromatography on 
Sephadex G-75  of zymosan-treated serum, endotoxin- 
treated serum, and trypsinized human C5 yield similar 
low  molecular  weight  fractions containing enzyme-re- 
leasing activity that is inhibitable by antibodies to human 
C5  but not by those to  human C3.  Furthermore, the 
activity is resistant to heat (56~  for 30 rain), is obtained 
in enhanced yields from serum containing epsilon-amino- 
caproic acid,  and is chemotactic for human PMN  (6). 
These properties are identical to those of C5a. 
Preparation  of Ferritin- Anti-Ferritin 
Ferritin (0.5  mg) was added to  1 ml of rabbit anti- 
horse ferritin (Cappel  Laboratories Inc.,  Downington, 
Pa.)  to form a  visible precipitate. The precipitate was 
allowed  to  settle,  washed  2  x  in  phosphate-buffered 
saline and suspended in 0.5 ml of buffered saline. The 
suspension was added to the reaction mixtures in a final 
concentration of 10% (vol/vol), and the cells were fixed 
after 5 and 15 min. 
Enzyme Assays 
Following incubation, the reaction mixtures were cen- 
trifuged  in the  cold  (755 g  for  10  rain) and  cell-free 
supernates removed for enzyme assays. Beta-glucuroni- 
dase was determined after 18 h of incubation with phe- 
nolphthalein glucuronidate as substrate (2).  Lysozyme 
was determined by the rate of lysis of Micrococcus lyso- 
deikticus (Worthington Biochemical Corp., Freehold, N. 
J.) measured by decrease in absorbancy at 450 nm (37). 
Crystalline hen egg-white lysozyme (Worthington Bio- 
chemical Corp.) was used as a standard. The cytoplasmic 
enzyme, lactate dehydrogenase (LDH),  was measured 
by the  method of  Wacker et al.  (29)  and used as  an 
indicator of cell viability. Total enzyme activities were 
determined  in  simultaneously  run,  duplicate  reaction 
mixtures to which had been added the detergent, Triton 
X-100 (0.2%) (Rohm and Haas Co., Philadelphia, Pa.). 
Electron  Microscopy 
Replicate cell suspensions were fixed at room temper- 
ature,  1 min after the addition of ZTS as described in 
(40), and embedded in Spurr's low viscosity epoxy. 
Morphometry 
All centrioles visible on six sections cut from each of 
three experiments were photographed at x  17,000 and 
printed at ￿  50,000 on high contrast paper. Pericentrio- 
lar microtubules were counted, as described (6), from all 
of the centrioles photographed. To test the possibility 
that microtubules in the cell periphery were more or less 
sensitive to colchicine than pericentriolar microtubules, 
we took micrographs of the right hand side of 9 consecu- 
tive cells per treatment from each of four separate exper- 
iments. To minimize observer bias, we selected the cyto- 
plasmic areas at a  magnification too low to distinguish 
microtubules, and subsequently focused at higher magni- 
fication. Negatives were printed to a final magnification 
of x  50,000 at high contrast. Each print was examined 
carefully and microtubules were counted, measured, and 
circled in ink. Profiles were considered to be microtu- 
bules if they had straight, parallel sides, 240-280 A long, 
and were  more  electron dense than the  ground  cyto- 
plasm.  The  volume  density  of microtubules was  then 
estimated by  superimposing a  coherent double  lattice 
test system (30). The coarse points, 2.5 cm apart, were 
used to measure cytoplasmic areas, and the fine points, 
0.25 cm apart, to measure microtubule density. A mini- 
mum  of  100,000  points or  250  ~2  of  cytoplasm  per 
treatment were examined for microtubules. 
RESULTS 
Effects of Cytochalasin  B 
and Colchicine  on 
PMN Ultrastructure 
Untreated PMN, prepared as described and ex- 
amined  in  thin  sections,  have  irregular  profiles 
with an occasional agranular pseudopod. The cen- 
trioles  and  Golgi  apparatus  are  usually  centrally 
located,  with nuclear  lobes behind and to  either 
side. The bulk of the granule population is in the 
pericentriolar cytoplasm  and  around  the  nuclear 
lobes.  The  granules  are  always  at  least  0.1  p.m 
from the plasma membrane. 
Cytochalasin  B-treated  PMN  cannot  maintain 
the  agranular  pseudopods  of untreated  cells and 
appear  rounded  with  small projections from  the 
cell  surface.  The  centrioles  and  Golgi  apparatus 
remain  centrally located,  with  nuclear  lobes  be- 
hind and to  either side.  The  granules are  evenly 
distributed throughout the  cytoplasm  but do  not 
approach the plasma membrane more closely than 
do those in untreated cells. Portions of the plasma- 
lemma are retracted and appear as electron-trans- 
parent vacuoles which extend inward toward  the 
pericentriolar cytoplasm (Fig. I a). Previous trans- 
mission  electron  microscope  studies  with  thor~ 
trast (10) as well as scanning electron microscopy 
(33) have established that these apparent vacuoles 
are  continuous  with  the  extracellular  space.  Mi- 
crotubules,  radiating  from  the  centrioles,  were 
sometimes observed adjacent to and parallel with 
244  THE  JOURNAL OF  CELL BIOlXmY " VOLUME 73,  1977 FIGu~  1  a  An  unstimulated, cytochalasin  B-treated  PMN.  The  centrioles  (arrow)  are  between  the 
nuclear lobes, and a  row of vacuoles (v) can be seen extending from the cell periphery to the centriolar 
region, x  11,000.1 b A  typical centriole from another unstimulated, cytochalasin B-treated PMN. Several 
microtubules (arrows) can be seen radiating from the centriole,  x  50,000.  1 c  A  PMN treated with both 
cytochalasin B  and T0  -~ M  colchicine. The centriole (arrow) is now located to one side of the cell rather 
than between the nuclear lobes, and most of the vacuoles (v) are in the peripheral cytoplasm, x  11,000. 
1 d  A  centriole from an unstimulated, colchicine-treated (10  -5 M) PMN sectioned in the same plane as the 
centriole in Fig.  1 b. No microtubules are visible in the adjacent cytoplasm, x  50,000. 
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gained from viewing numerous such cells was that 
the centrioles constituted a focus of symmetry and 
that microtubules formed the architectural frame- 
work  (Fig.  l b).  PMN  exposed  to  colchicine 
(10-5-10  -e  M)  appeared  superficially  like  un- 
treated cells. Colchicine did not alter the distribu- 
tion of granules or the ability of the cells to form 
agranular  pseudopods.  Closer  examination 
showed  that  the  centrioles and  Golgi apparatus 
were  not in their  usual position but were  most 
frequently found between a nuclear lobe and the 
plasma membrane. Few or no microtubules were 
seen in the cytoplasm of these cells. Cytochalasin 
B-treated cells exposed to colchicine also showed 
the displacement of the centrioles and Golgi appa- 
ratus and the absence of the normal complement 
of microtubules. In addition, the vacuoles formed 
by the retracted plasma membrane were limited to 
the cell periphery (Figs. 1 c and d). 
Effects of ZTS on  Ultrastructure of 
Untreated and of Cytochalasin 
B- Treated PMN 
Untreated PMN  stimulated by ZTS had  very 
irregular profiles with more pseudopodial exten- 
sions than resting cells.  More microtubules were 
also present in the cytoplasm of stimulated cells, 
but they were never seen to extend into the pseu- 
dopods. No morphological evidence of degranula- 
tion was seen and no enzyme release was detected 
biochemically. Cytochalasin B-treated  PMN  ex- 
posed to ZTS also had increased numbers of mi- 
crotubules compared to  similarly treated  resting 
cells,  and  the  radial  symmetry around the  cen- 
trioles was striking (Figs.  2 and 3).  Massive de- 
granulation occurred, and the vacuoles increased 
in size and number and approached the centrioles 
in linear arrays. Continuities  between the internal- 
ized  and  external plasma membrane were  seen 
frequently. So  much membrane appeared to  be 
added by granule fusion that degranulating cells, 
sectioned through a  centriole, sometimes resem- 
bled flowers with numerous petals. Long microtu- 
bules were commonly seen running  parallel with a 
row of vacuoles, extending from a centriole to the 
cell perimeter. Short, dense filaments, up to 250 
nm long by 10-20 nm wide, were present in all 
cytochalasin B-treated PMN after stimulation by 
ZTS but not before, and were oriented tangential 
to  plasmalemmal or  vacuolar  membranes. The 
dense filaments were always observed within less 
dense aggregates of 40-60 .~ filaments, and had 
the  appearance of PMN  myosin aggregates  pre- 
pared in vitro (28). 
Effect of ZTS on the Ultrastructure of 
PMN Pretreated with Both 
Colchicine and Cytochalasin B 
PMN treated with high concentraitons of colchi- 
cine before  stimulation by  ZTS  had  few  or  no 
visible microtubules. The vacuoles were irregular 
in outline, generally were  more peripherally lo- 
cated, and their position bore no relationship to 
the  position of the centriole which was also fre- 
quently located in the cell periphery (Figs. 4 and 
5).  With 5  x  10 -7 M  colchicine, more microtu- 
bules were visible and the centrioles retained their 
central position, but many vacuoles remained in 
the  cell  periphery.  Only  a  few  vacuoles  ap- 
proached the  pericentriolar cytoplasm. Cells ex- 
posed to 10 -7 M or 10 -a M colchicine were indis- 
tinguishable  from  controls  without  colchicine. 
High concentrations of colchicine did not alter the 
appearance of dense filaments (Figs. 6 a and b). 
Effect of Colchicine on Translocation 
of Phagocytic Vacuoles 
PMN  exposed  to immune complexes ingested 
them with great avidity and formed many small 
phagocytic vacuoles. When sections that included 
a centriole were examined, the vacuoles were seen 
to  have  a  nonrandom distribution. Most  of the 
vacuoles were on the same side of the cell as the 
centriole  and  approached  very  close  to  it  (Fig. 
7a). They were frequently seen to be closely asso- 
ciated with microtubules. 
Colchicine-treated PMN (10  -5 M) also ingested 
immune complexes, but the vacuoles had a  ran- 
dom distribution and were  not preferentially lo- 
cated on one side or the other of the cell. Vacuoles 
were not commonly seen near the centriole (Fig. 
7b), and, when they were,  that centriole had  a 
few persistent microtubules. 
Effect of Colchicine on 
Enzyme Release 
Cytochalasin B-treated PMN  exposed  to  ZTS 
for  5  min released  22.2  •  1.7%  of total beta- 
glucuronidase and 35.3  •  3.1%  lysozyme. This 
release was  not influenced by colchicine concen- 
trations of 10 -7 M or less. Colchicine concentra- 
tions above  10 -7  inhibited enzyme release  in a 
246  THE JOUIt~AL OF CELL Bxot~at~y. VOLUME 73,  1977 FIGURE 2  A  cytochalasin  B-treated PMN exposed to ZTS for one minute. The vacuoles (v) are more 
numerous and extend from the centriole (large arrow) to the cell periphery. Continuities between vacuoles 
and between vacuoles and plasma membrane are common (curved arrows). Dense filaments (small arrows) 
can be seen in the upper left of the figure. ￿  18,000. 
dose-related  fashion  (see  Table  I).  LDH  release 
did not vary significantly from controls. 
Effects of Colchicine on 
Microtubule Assembly 
The mean number of microtubules visible in the 
centriolar  region  of  cytocbalasin  B-treated  ceils 
preincubated with a  high-dose (10 -5 M) of colchi- 
cine  was  3.2  --- 0.6,  compared  to  21.5  -+  1.7  in 
control  cells.  This  was  not  significantly different 
from the mean number seen in cells without cyto- 
chalasin  B.  Those  microtubules  visible after  col- 
chicine treatment were morphologically similar to 
those  in  control  PMN.  Stimulation  with  ZTS in- 
creased the number of microtubules visible in un- 
treated cells and in cells treated with less than 10 -~ 
HOFFSTEIN ET AL.  Microtubules  and Enzyme Release from Human Leukocytes  247 FIGURE  3  a  A cell similar to that in Fig. 1. Degranulation is almost complete and the radial symmetry 
around the centriole is striking,  x  16,000.3 b A higher magnification  view of the centriolar region of the 
stimulated cell  in Fig.  3a.  Many microtubules (arrows) are visible  radiating from centriole-associated 
organizing  sites. It can be seen in this micrograph that the radial arrangement of vacuoles and organeUes 
around the centriole is paralleled by a similar radial  arrangement of microtubules, x  50,000. 
248  THE  JOURNAL OF  CELL BIOLOGY. VOLUME 73,  1977 Fxou~  4  A cytochalasin  B-treated PMN preincubated with 10  -5 M colchicine for one hour and exposed 
to ZTS for one minute. The centrioles (large  arrow) can be seen in the lower left of the figure, and large 
vacuoles are scattered around the cell periphery. Continuity between a vacuole and the plasma membrane 
can be seen near the top of the figure (curved arrow). Regions of cytoplasm can be seen that still contain 
many granules, and dense filaments (small arrows) are present adjacent to vacuoles in the upper portion of 
the figure, x  18,000. 
HOI~'STEIN ET  AL.  Microtubules  and Enzyme Release from Human Leukocytes  249 FIGURE  5  a  Another cell treated as in Fig. 4. The vacuoles are large and without orientation with respect 
to the centriole (arrow). Dense filaments are present adjacent to the plasma membrane in the lower right 
of the figure (small arrows), and regions of cytoplasm without vacuoles contain numerous granules,  x 
16,000.5b  A  higher magnification view of the centriolar region of the colchicine-treated, stimulated cell 
shown in Fig. 5 a. No microtubules are visible adjacent to the centriole-associated microtubule organizing 
site.  ￿  50,000. Flot~ 6  a A higher magnification  view of a vacuole from a cytochalasin  B-treated, ZTS-stimulated cell 
showing a vacuole with tangentially arranged,  dense  filaments and an adjacent microtubule  (arrow).  x 
50,000.6b A portion of a cell treated with both cytochalasin B and colchicine (10  -5 M), then stimulated 
with ZTS. Many dense  filaments can be seen, but no microtubules. Discharge of granule contents into 
vacuoles (arrows) is visible near the filaments, x  50,000. 
colchicine, but assembly was inhibited at higher 
concentrations and few microtubules were visible 
at 10 -5 M or 10 -6 M (Fig. 4 and Table I). Colchi- 
cine inhibition of ZTS-stimulated microtubule as- 
sembly was  also  observed in cells without cyto- 
chalasin B. 
Since the enzyme release studies indicated that 
inhibition  of beta-glucuronidase  release was signif- 
icantly greater at 10  -5 M than 10 -6 M, a morpho- 
metric  study  of  microtubules in  the  peripheral 
cytoplasm was undertaken to determine whether 
there  was a  corresponding difference at the  two 
dose levels. Whereas there  was a  marked incre- 
ment in the  number of microtubules per square 
micron in untreated cells after  ZTS stimulation 
(0.23  -+ 0.06 to 0.42 -+ 0.05), pretreatment with 
colchicine prevented  this  increase.  Instead,  the 
frequency of visible microtubules was below that 
in resting control cells. After 10  -5 colchicine the 
frequency was 0.05  -+ 0.02, and after 10  -6 M the 
frequency  was  0.14  _  0.03  (Table  II).  Point 
counting estimates of microtubule volume density 
confirmed the results obtained by counting. The 
ratio of points on microtubules to points on cyto- 
plasm increased in untreated cells after stimulation 
but was below resting levels in high-dose colchi- 
cine-treated cells. Again, the  volume density of 
microtubules appeared to be somewhat higher in 
10  -8  as  compared  to  10 -5  M  colchicine-treated 
cells (see Table III). 
DISCUSSION 
Numerous studies from this and other laboratories 
have shown that release of lysosomal enzymes to 
the  outside  of  PMN  during phagocytosis  is  af- 
fected by agents that influence the state of assem- 
bly of microtubules (18, 32, 39, 41, 42), and have 
interpreted these data as applying directly to fu- 
sion of lysosomes with phagosomes (14,  15,  32, 
33,  41,  42).  In  these  earlier  studies,  in  which 
selective  enzyme  release  from  stimulated PMN 
was  measured, agents known to  promote  disas- 
sembly of microtubules, i.e., coichicine and vin- 
blastine, decreased  enzyme release.  In contrast, 
D20,  which  increases microtubule stability (16, 
25), increased enzyme release (42). This interpre- 
tation was supported by data which showed inhibi- 
tion of phagocytic degranulation  by colchicine (10, 
39). Moreover, cyclic nucleotide-modulated  incre- 
ments and decrements in enzyme release (cGMP 
HOFVSTEr~ El"  AL.  Microtubules  and Enzyme Release from Human Leukocytes  251 FIGURE  7  a The pericentriolar cytoplasm of an untreated PMN exposed for 5 min to ferritin- anti-ferritin 
immune complexes. Many microtubules radiate  from  centriole-associated microtubule  organizing sites. 
Fourteen  ferritin-containing phagocytic vacuoles  (arrowheads)  are  visible in  this small  portion  of the 
cytoplasm, x  25,000.7b A corresponding portion of a colchicine-treated PMN (10  -5 M) similarly exposed 
to ferritin- anti-ferritin. In contrast to the cell in Fig. 7a, only a few microtubules and three phagocytic 
vacuoles are visible,  x  25,000. 1'  cAMP  ~ )  correlated  closely  with  increments 
and decrements  in microtubule  numbers  (33).  Fi- 
nally,  increased  numbers  of  microtubules  were 
consistently  seen  in  stimulated  as  compared  to 
resting cells. The  data presented  here  show that, 
in  both  cytochalasin  B-treated  and  untreated 
PMN,  colchicine  causes a  dose-related  inhibition 
of  microtubule  assembly.  Coichicine  concentra- 
tions  which  affect  microtubule  assembly also  in- 
hibit  lysosomal enzyme  release  in  a  dose-related 
fashion, but concentraitons which cause the virtual 
TABLE  I 
Inhibition of Microtubule Assembly in, and Enzyme 
Release from,  Cytochalasin  B-Treated Human 
PMN Stimulated by ZTS* 
Colehicine 
Enzyme release (%)w 
Mean micro- 
tubule num-  Beta-Glueu- 
bets:i:  ronidasr  Lysozyme 
[2 
0  35.6 •  2.0  100  100 
10  -8  32.2 •  2.1  101.8 -+ 6.5  95.6 •  1.1 
10  -~  36.0 -+ 2.5  91.4 -+ 5.2  99.7 •  5.3 
5 x 10  -7  11.6 •  1.311  78.5 •  3.911  86.7 •  4.211 
10  -e  4.0 •  0.4[t  74.1 •  3.411  82.7 •  3.41J 
10  -~  2.8 -+ 0.4[I  59.8 •  3.9[[  61.2 •  4.211 
* Cells were preineubated  with cytochalasin  B (5.0 g.g/ral) for 10 rain and 
exposed to ZTS (10%, vol/vol) for 5 rain at 37~ 
:[: Microtubules  within 4 /.~ra~  centered on a centriole. Mean •  SEM (n = 
17). 
w  100% = enzyme  release from cells exposed  to ZTS in the absence of 
colchicine:  beta-glucuronidase  ~ 70.7 -  3.9/.tg  phenolphthalein  per 2 ￿  10  ~ 
PMN; lysozyrae  = 2.8 -+ 0.3/.Lg  crystalline  hen-white  lysozyme  equivalents 
per 2 x 10  e PMN. Enzyme  release flora resting  cells  (not exposed  to ZTS) 
was 3.8 •  0.7 and 1.8 -  0.3, respectively.  Release  from  unstiraniated  cells 
was not altered significantly  by pretreatraent with colchicine.  Total activity 
released by 0.2% Triton X-100: beta-glucuronidase  = 262 •  20; lysozyme 
= 7.8 •  1.2. 
1[ Significant  at P < 0.005 vs. control of 100%. 
disappearance  of  microtubules  inhibit  enzyme 
release  by  no  more  than  40%  (31,  41).  Thus, 
lysosomal enzyme release from PMN  is influenced 
by the state of assembly of microtubules but not in 
a  simple direct  way. 
Lysosomal enzyme secretion to the external me- 
dium in response to a  given stimulus reflects vary- 
ing rates of:  (a)  cell  motility,  or chemotaxis;  (b) 
phagocytosis;  (c)  translocation  of phagosomes  to 
the granular cytoplasm; and (d) fusion of granules 
with complete or incomplete (open)  phagosomes. 
In order to understand the role of microtubules in 
enzyme release from phagocytes, we  must clearly 
distinguish the steps involved. Pesanti and Axline 
(19, 20) have shown that doses of colchicine suffi- 
cient  to  inhibit  microtubule  assembly  in  resting 
macrophages have no effect on fusion as measured 
by transfer of acid phosphatase to phagocytic vac- 
uoles  or  degradation  of  ingested  material,  al- 
though  phagocytosis per se  is reduced.  They  sug- 
gest that fusion of organelles may be modulated by 
contractile  elements  (microfilament  system)  but 
not by means of microtubules. 
In the  present combined  morphologic  and bio- 
chemical study of the role  of microtubules  in en- 
zyme release, we have used ZTS, a  soluble stimu- 
lus  for  enzyme  release.  Its  active  component 
(C5a)  is  a  low  molecular  weight  protein  which 
makes  contact with  all  areas of the plasma mem- 
brane simultaneously and equally, and all enzymes 
released by fusion of lysosomal granules with the 
plasma membrane  appear  in the surrounding me- 
dium.  Thus,  cell  motility  and  phagocytosis  are 
eliminated  as  possible  variables.  Therefore,  the 
only variables remaining  to  be  influenced by mi- 
TABLE II 
Effect of Colchicine on Microtubule Frequency* in Peripheral Cytoplasm of Cytochalasin 
B-Treated Human PMN Stimulated by ZTS~- 
Resting  cells  Stimulated cells 
Experiment  (No colchicine)  (Colchicine concentrations) 
None  10  -~ M  10  -e M 
1  0.23  0.60  0.11  0.15 
2  0.33  0.43  0.06  0.09 
3  0.21  0.49  0.07  0.19 
4  0.14  0.33  0.12  0.15 
M  •  SEM  0.23  •  0.04w  0.46  •  0.06  0.09  •  0.01w  0.15  •  0.02w 
* Mean number of microtubules per square micron of peripheral cytoplasm. Determined from 9 
micrographs per treatment per experiment. 
~: Cells were preincubated with cytochalasin B (5.0 ~tg/ml) for 10 min and with colchicine for 60 
min, then exposed to ZTS (10%  vol/vol) for 1 min at 37~ 
w P  <  0.002 vs. stimulated cells prepared without colchicine. 
I1 P  <  0.025 vs. 10  -5 M  colchicine by matched pair t  test. 
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Effect of Colchicine on Volume Density (x 10  -4) * of Microtubules  in Peripheral Cytoplasm  of 
Cytochalasin  B-Treated  Human PMN Stimulated  by ZTS~t 
Resting cells  Stimulated cells 
Experiment  (No eolchieine)  (Colchicine concentrations) 
None  10  -s M  10  4  M 
1  12.5  25.7  5.6  5.8 
2  8.3  11.6  1.4  3.5 
3  8.1  19.0  1.7  3.1 
4  5.9  14.3  3.0  5.1 
M -+ SEM  8.8 -+ 1.4w  17.7 -  3.1  2.9 +-- 1.0w  4.4 +-- 0.6w 
* Ratio of test points on microtubule profiles to total points on cytoplasm. Determined from 9 
micrographs per treatment per experiment. 
~t Cells were preincubated with cytochalasin  B (5.0/~g/ml) for 10 min and with colchicine  for 60 
min, then exposed to ZTS (10% vol/vol) for 1 min at 37~ 
w  P <  0.005 vs. stimulated cells by matched pair t test. 
IIP < 0.01 vs. 10  -5 M colchicine by matched pair t test. 
crotubules  are  the  translocation  of  stimulated 
plasma membrane (now a surrogate phagosome) 
into granule-rich areas within the cytoplasm and/ 
or  the  fusion of lysosomal membranes with the 
plasma  membrane: processes  (c)  and  (d).  The 
data suggest that it is the former rather than the 
latter process that is microtubule dependent. 
The morphologic correlate of reduced microtu- 
bule assembly in unstimulated PMN is an apparent 
disorganization of the  central region of the  cell, 
with the centrioles and Golgi apparatus displaced 
from  their  usual  position  between  the  nuclear 
lobes. The agranular cytoplasm appears not to be 
adversely affected by colchicine and remains capa- 
ble of forming pseudopods.  Cytochalasin B  pre- 
vents the formation of pseudopods, but the peri- 
cortical  cytoplasm  retains  sufficient integrity to 
exclude granules. 
Upon  stimulation, microtubules were  seen  in 
greater  numbers in both  cytochalasin B-treated 
and  untreated  PMN  than  in  resting  cells.  In- 
creased microtubule volume density was also doc- 
umented by point counting morphometry. Inter- 
estingly, a similar volume density was obtained for 
resting PMN  as  was  obtained by  Reaven et  al. 
(23)  for rat  parathyroid glands. The increase in 
microtubule numbers was seen throughout the cy- 
toplasm, but microtubules were most conspicuous 
extending in a radial pattern from centriole-associ- 
ated organizing sites. Invaginations of the plasma 
membrane in cytochalasin B-treated, ZTS-stimu- 
lated PMN were prominent along these radiating 
microtubules in  the  pericentriolar cytoplasm  of 
cells  permitted  to  assemble  microtubules. Cells 
that were prevented by colchicine from assembling 
microtubules had a more random pattern of invag- 
inations. In the absence of microtubule assembly, 
there appeared to be no coordinated translocation 
of stimulated plasma membrane to the centriolar 
region, a finding in keeping with the observations 
of Freed and Lebowitz (5). 
Unfortunately, although ZTS induces microtu- 
bule assembly in both cytochalasin B-treated and 
untreated PMN, enzyme release occurs only from 
stimulated  cells  pretreated  with  cytochalasin  B 
(6). This may be because cytochalasin B inhibits 
the  gelation  of  actin  by  interfering with  actin- 
binding protein interactions, although it does not 
depolymerize actin filaments or inhibit the Mg  §247 
ATPase  activity  of  a  cofactor-activated  actino- 
myosin (7, 22). Phagocytosis is adversely affected 
by cytochalasin B-treatment but not stimulus-cou- 
pled  secretion.  To  ensure  that  the  phenomena 
observed  were  not  due  to  cytochalasin B-treat- 
ment, we also examined the morphologic conse- 
quences of inhibition of microtubule assembly in 
cells without cytochalasin B which were permitted 
to phagocytose small particles of immune precipi- 
tates. These true phagosomes were  also translo- 
cated  to  the  centriole region when  microtubule 
assembly was permitted and were closely associ- 
ated with microtubules. When microtubule assem- 
bly was inhibited by colchicine, phagosomes were 
distributed randomly throughout the cytoplasm. 
The  data  suggest that  translocation of phago- 
somes within the cytoplasm is modulated by mi- 
crotubule assembly rather  than fusion itself and 
that correlations between tubule assembly and dis- 
assembly  and  enhanced  or  diminished enzyme 
release (33) probably reflect events earlier in the 
secretory process of PMN. Although our data do 
not show that fusion is unaffected by colchicine, it 
254  THE JOURNAL OF CELL BmLOGY ￿9 VOLUME 73,  1977 is significant that inhibition of microtubule assem- 
bly inhibits enzyme release by no more than 40%. 
Microtubules, therefore, appear to be involved in 
maintaining the internal organization of PMN and 
the  topologic  relationships between  their  organ- 
elles  and  the  plasma  membrane.  Assembly  may 
enhance, or disassembly diminish, the chances for 
contact  between  PMN  granules  and  stimulated 
areas of the plasma membrane. Other structures, 
perhaps  contractile  proteins,  may  play  a  more 
direct role  in permitting fusion between granules 
and  phagosomes  or  the  membrane  of  the  cell 
itself. 
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